Being the first nation to begin mass vaccinations in December, over 17 million UK resident have received at least a first dose so far.
The new findings point to the dangers of countries easing restrictions as the variant takes hold in the
Even with a handful of available treatments efforts, to repurpose other drugs or discover new ones have not had much success
Eli Lilly's, Regeneron's antibody drugs against COVID-19 raise hopes of preventing infection, hospitalisation
Eli Lilly’s study of 1,035 outpatients recently diagnosed with COVID-19 revealed that only 2 percent needed hospitalisation on its drug.
WHO has identified 42 candidate vaccines in clinical trials, ten of which are in advanced 'Phase 3 trials in human volunteers.